Metabolomics in infectious diseases and drug discovery V Tounta, Y Liu, A Cheyne, G Larrouy-Maumus Molecular omics 17 (3), 376-393, 2021 | 111 | 2021 |
Purine metabolism controls innate lymphoid cell function and protects against intestinal injury S Crittenden, A Cheyne, A Adams, T Forster, CT Robb, J Felton, GT Ho, ... Immunology and cell biology 96 (10), 1049-1059, 2018 | 39 | 2018 |
Expression of a novel mycobacterial phosphodiesterase successfully lowers cAMP levels resulting in reduced tolerance to cell wall–targeting antimicrobials M Thomson, Y Liu, K Nunta, A Cheyne, N Fernandes, R Williams, ... Journal of Biological Chemistry 298 (8), 2022 | 15 | 2022 |
Nipah virus disease: what can we do to improve patient care? MZ Hassan, T Shirin, SM Satter, MZ Rahman, J Bourner, A Cheyne, ... The Lancet Infectious Diseases, 2024 | 9 | 2024 |
Community involvement in an outbreak—one year on for mpox A Cheyne, I Muchamore, H Tulunay, A Rojek, L Peto, P Horby Clinical Infectious Diseases 79 (1), 278-280, 2024 | 3 | 2024 |
Systematic Review of Scales for Measuring Infectious Disease–Related Stigma A Paterson, A Cheyne, B Jones, S Schilling, L Sigfrid, J Stolow, L Moses, ... Emerging Infectious Diseases 30 (3), 519, 2024 | 3 | 2024 |
Modulation of the cAMP levels with a conserved actinobacteria phosphodiesterase enzyme reduces antimicrobial tolerance in mycobacteria M Thomson, K Nunta, A Cheyne, Y Liu, A Garza-Garcia, ... bioRxiv, 2020 | 2 | 2020 |
Digital health interventions in primary care in low-and middleincome countries: a systematic scoping review protocol JJ Nathan, D Agarwal, IT Peres, LSL Bastos, N Resende, S Hamacher, ... International Society of Global Health, 2024 | 1 | 2024 |
Comparative transcriptomic analysis of whole blood mycobacterial growth assays and tuberculosis patients’ blood RNA profiles P Bachanová, A Cheyne, C Broderick, SM Newton, M Levin, M Kaforou Scientific reports 12 (1), 1-13, 2022 | 1 | 2022 |
Mpox stigma in the UK and implications for future outbreak control A Paterson, A Cheyne, H Tulunay, C Orkin, W Nutland, J Dunning, ... | | 2025 |
Engaging the community during PLATINUM: A randomised controlled trial of tecovirimat in non-hospitalised mpox patients A Cheyne, H Tulunay, L Phillips, A Rojek, L Peto, P Horby TROPICAL MEDICINE & INTERNATIONAL HEALTH 28 (SUPP 1), 388-388, 2023 | | 2023 |
Understanding the evolution of Mycobacterium tuberculosis lineages using an integrated genomics and metabolomics approach A Cheyne, A Broda, N Krishnan, B Robertson, M Kaforou, ... Access Microbiology 2 (7A), 696, 2020 | | 2020 |